Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:05 PM EDT

Astrazeneca (AZN) Capital Expenditures Growth (3y) (2012 - 2026)

Analysis

Astrazeneca (AZN) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn -
2 Hsbc Holdings 362.62 Bn 362.62 Bn - -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn 53.85%
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn -41.38%
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn -
6 Bhp 216.07 Bn 197.52 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.09 Bn 195.06 Bn - -
9 Unilever 139.31 Bn 132.28 Bn - -
10 Hdfc Bank 117.84 Bn 80.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -41.38%
Mar 31, 2026 -30.35%
Jun 30, 2025 -37.59%
Mar 31, 2025 -25.12%
Dec 31, 2024 -29.90%
Sep 30, 2024 -17.05%
Jun 30, 2024 -9.87%
Mar 31, 2024 -23.76%
Jun 30, 2023 -13.64%
Mar 31, 2023 -9.92%
Jun 30, 2022 -34.14%
Mar 31, 2022 -7.97%
Dec 31, 2021 -0.84%
Sep 30, 2021 -2.42%
Jun 30, 2021 -1.80%
Mar 31, 2021 -1.08%
Dec 31, 2020 8.70%
Sep 30, 2020 8.74%
Jun 30, 2020 11.23%
Mar 31, 2020 13.36%